HILLEVAX INC's ticker is and the CUSIP is 43157M102. A total of 92 filers reported holding HILLEVAX INC in Q2 2024. The put-call ratio across all filers is - and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2024 | $4,167,628 | -20.0% | 250,609 | -22.8% | 2.71% | -7.7% |
| Q4 2023 | $5,209,830 | +43.3% | 324,600 | +20.1% | 2.93% | +20.4% |
| Q3 2023 | $3,635,791 | +235.3% | 270,319 | +328.5% | 2.44% | +231.6% |
| Q2 2023 | $1,084,311 | +884.3% | 63,078 | +846.5% | 0.74% | +807.4% |
| Q1 2023 | $110,156 | – | 6,664 | – | 0.08% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Frazier Life Sciences Management, L.P. | 9,285,682 | $101,493,000 | 9.58% |
| Qiming U.S. Ventures Management, LLC | 558,923 | $6,109,000 | 8.48% |
| Abingworth LLP | 1,838,486 | $19,929,000 | 6.38% |
| Samsara BioCapital, LLC | 762,577 | $8,335,000 | 2.22% |
| SEVEN GRAND MANAGERS, LLC | 34,386 | $376,000 | 0.85% |
| StepStone Group LP | 676,567 | $7,395,000 | 0.79% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 2,617,948 | $28,614,000 | 0.59% |
| RA Capital Management | 1,760,019 | $19,237,000 | 0.51% |
| Perceptive Advisors | 764,907 | $8,360,000 | 0.26% |
| BVF INC/IL | 382,513 | $4,181,000 | 0.20% |